*/
Casey Randall explores the benefits of prenatal paternity testing and explains how the test is performed
A non-invasive prenatal paternity (NIPP) test is the safest option for anyone looking to establish paternity before a baby is born and can be extremely beneficial for legal purposes.
As the only testing laboratory in the UK to be UKAS-accredited for prenatal paternity testing, we are often asked about the circumstances in which prenatal paternity testing is most suitable for court proceedings. This includes:
While in the past the court would have been left in the dark about a child’s paternity until after birth, advances in DNA analysis mean that it is now possible to perform a NIPP test as early as seven weeks into pregnancy. Demand is on the rise as more people discover the benefits of this type of test. We have seen a 47% increase in consumer sales of prenatal paternity tests (2021) versus pre-pandemic levels (AlphaBiolabs DNA testing data (2019-2021)).
DNA samples required for a legally admissible prenatal paternity test must be collected under strict chain of custody conditions. This means that a trained sample collector will ensure samples are obtained correctly and from the right individuals, before they are safely transported back to the lab.
Unlike other types of prenatal paternity test that require cells to be taken from the placenta (chorionic villus sampling or CVS test) or a sample of amniotic fluid (amniocentesis), a NIPP test only requires a blood sample from the mother and cheek (buccal) DNA swabs from the mother and the alleged father. Therefore, a NIPP test – such as that offered by AlphaBiolabs – is 100% risk free for mother and baby.
To perform the test, a blood sample is collected from the mother by a trained medical professional such as a phlebotomist, nurse, or another medical practitioner, and promptly returned to the laboratory to be analysed. This reduces the likelihood of the blood degrading in transit, which can render a sample unusable.
Cheek (buccal) swabs can be collected from the mother and alleged father at a convenient time, and simply requires a swab to be rubbed quickly and painlessly on the inside of the cheek to collect DNA. Although the mother and alleged father’s samples do not need to be collected at the same location, it is advised that they are collected around the same time, to ensure testing can begin as soon as the mother’s blood sample is received.
Once the mother’s and alleged father’s samples have been received by the testing laboratory, DNA is extracted from both samples. The very latest scientific techniques ensure the baby’s DNA can be identified within the mother’s blood sample. Short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) are used to perform NIPP testing, with expert geneticists able to analyse the genetic markers in each DNA profile.
Every person inherits half of their DNA from their mother and half from their father. This means that the foetus will have two copies of each STR marker, known as alleles, in their DNA profile – one from each of the biological parents. By comparing the alleles at each marker with the DNA collected from the mother and the alleged father, geneticists can determine whether the man is the biological father of the baby; provided there is sufficient foetal DNA within the mother’s blood sample.
Prenatal paternity testing can provide the vital evidence needed for counsel to reach important decisions about a child’s future.
An AlphaBiolabs’ prenatal paternity test can be used to test more than one alleged father, with results available in four-to-seven days. A comprehensive statement of witness report is included as standard. Legal customers can also benefit from free sample collection at any of our 11 nationwide walk-in centres.
For expert advice on which drug test is best for your client, call the AlphaBiolabs Customer Services team on 0330 600 1300 or email testing@alphabiolabs.com and a member of the Legal Team will be in touch.
For further information please visit: https://www.alphabiolabs.co.uk
A non-invasive prenatal paternity (NIPP) test is the safest option for anyone looking to establish paternity before a baby is born and can be extremely beneficial for legal purposes.
As the only testing laboratory in the UK to be UKAS-accredited for prenatal paternity testing, we are often asked about the circumstances in which prenatal paternity testing is most suitable for court proceedings. This includes:
While in the past the court would have been left in the dark about a child’s paternity until after birth, advances in DNA analysis mean that it is now possible to perform a NIPP test as early as seven weeks into pregnancy. Demand is on the rise as more people discover the benefits of this type of test. We have seen a 47% increase in consumer sales of prenatal paternity tests (2021) versus pre-pandemic levels (AlphaBiolabs DNA testing data (2019-2021)).
DNA samples required for a legally admissible prenatal paternity test must be collected under strict chain of custody conditions. This means that a trained sample collector will ensure samples are obtained correctly and from the right individuals, before they are safely transported back to the lab.
Unlike other types of prenatal paternity test that require cells to be taken from the placenta (chorionic villus sampling or CVS test) or a sample of amniotic fluid (amniocentesis), a NIPP test only requires a blood sample from the mother and cheek (buccal) DNA swabs from the mother and the alleged father. Therefore, a NIPP test – such as that offered by AlphaBiolabs – is 100% risk free for mother and baby.
To perform the test, a blood sample is collected from the mother by a trained medical professional such as a phlebotomist, nurse, or another medical practitioner, and promptly returned to the laboratory to be analysed. This reduces the likelihood of the blood degrading in transit, which can render a sample unusable.
Cheek (buccal) swabs can be collected from the mother and alleged father at a convenient time, and simply requires a swab to be rubbed quickly and painlessly on the inside of the cheek to collect DNA. Although the mother and alleged father’s samples do not need to be collected at the same location, it is advised that they are collected around the same time, to ensure testing can begin as soon as the mother’s blood sample is received.
Once the mother’s and alleged father’s samples have been received by the testing laboratory, DNA is extracted from both samples. The very latest scientific techniques ensure the baby’s DNA can be identified within the mother’s blood sample. Short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) are used to perform NIPP testing, with expert geneticists able to analyse the genetic markers in each DNA profile.
Every person inherits half of their DNA from their mother and half from their father. This means that the foetus will have two copies of each STR marker, known as alleles, in their DNA profile – one from each of the biological parents. By comparing the alleles at each marker with the DNA collected from the mother and the alleged father, geneticists can determine whether the man is the biological father of the baby; provided there is sufficient foetal DNA within the mother’s blood sample.
Prenatal paternity testing can provide the vital evidence needed for counsel to reach important decisions about a child’s future.
An AlphaBiolabs’ prenatal paternity test can be used to test more than one alleged father, with results available in four-to-seven days. A comprehensive statement of witness report is included as standard. Legal customers can also benefit from free sample collection at any of our 11 nationwide walk-in centres.
For expert advice on which drug test is best for your client, call the AlphaBiolabs Customer Services team on 0330 600 1300 or email testing@alphabiolabs.com and a member of the Legal Team will be in touch.
For further information please visit: https://www.alphabiolabs.co.uk
Casey Randall explores the benefits of prenatal paternity testing and explains how the test is performed
Sam Townend KC explains the Bar Council’s efforts towards ensuring a bright future for the profession
Giovanni D’Avola explores the issue of over-citation of unreported cases and the ‘added value’ elements of a law report
Louise Crush explores the key points and opportunities for tax efficiency
Westgate Wealth Management Ltd is a Partner Practice of FTSE 100 company St. James’s Place – one of the top UK Wealth Management firms. We offer a holistic service of distinct quality, integrity, and excellence with the aim to build a professional and valuable relationship with our clients, helping to provide them with security now, prosperity in the future and the highest standard of service in all of our dealings.
Is now the time to review your financial position, having reached a career milestone? asks Louise Crush
If you were to host a dinner party with 10 guests, and you asked them to explain what financial planning is and how it differs to financial advice, you’d receive 10 different answers. The variety of answers highlights the ongoing need to clarify and promote the value of financial planning.
Most of us like to think we would risk our career in order to meet our ethical obligations, so why have so many lawyers failed to hold the line? asks Flora Page
If your current practice environment is bringing you down, seek a new one. However daunting the change, it will be worth it, says Anon Barrister
Creating advocacy opportunities for juniors is now the expectation but not always easy to put into effect. Tom Mitcheson KC distils developing best practice from the Patents Court initiative already bearing fruit
National courts are now running the bulk of the world’s war crimes cases and corporate prosecutions are part of this growing trend, reports Chris Stephen
Sam Townend KC explains the Bar Council’s efforts towards ensuring a bright future for the profession